ReviewEnvironmental science and ecotechnology2025
Global antibiotic hotspots and risks: A One Health assessment.
Review in Environmental science and ecotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Mass Flux Analysis Reveals the Presence and Fate of Antimicrobials in Hospital Effluent, Wastewater Treatment Plant, and River Environments.Antibiotics (Basel, Switzerland) · 2026Article
- Probing biofilm development, stress response and heterogeneity-spectroscopic characterization of single and multi-species consortia.NPJ biofilms and microbiomes · 2026Article
- Luminescence-Based Strategies for Detecting β-Lactamase Activity: A Review of the Last Decade.Life (Basel, Switzerland) · 2026Review
- Tetracyclines in the Modern Era: Global Consumption, Antimicrobial Resistance, Environmental Occurrence, and Degradation Techniques.Antibiotics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotics are increasingly prevalent in global environments, driving antimicrobial resistance and disrupting microbial cycling. These impacts pose threats to human, animal, and environmental health. Therefore, addressing this emergent issue necessitates a One Health framework that integrates these interconnected dimensions. Here we systematically review 137 antibiotics across diverse global environmental compartments. We find that sulfonamides, macrolides, quinolones, and tetracyclines are globally ubiquitous, particularly prevalent in Asia and Africa, whereas β-lactams dominates in Europe. Hierarchical clustering revealed ten priority antibiotics in liquid phases and eight in solid phases requiring urgent attention. Regional analysis indicated the highest antibiotic concentrations within wastewater treatment plant liquids in the Americas and surface waters in Africa, with generally lower levels detected in Asia and Europe. Utilizing a One Health assessment framework, we integrated Predicted No-Effect Concentrations for antibiotic resistance selection (PNEC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.